Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Airsculpt Technologies (AIRS) Cash & Equivalents: 2020-2024

Historic Cash & Equivalents for Airsculpt Technologies (AIRS) over the last 5 years, with FY2024 value amounting to $8.2 million.

  • Airsculpt Technologies' Cash & Equivalents fell 949.43% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year decrease of 949.43%. This contributed to the annual value of $8.2 million for FY2024, which is 1975.25% down from last year.
  • Airsculpt Technologies' Cash & Equivalents amounted to $8.2 million in FY2024, which was down 1975.25% from $10.3 million recorded in FY2023.
  • In the past 5 years, Airsculpt Technologies' Cash & Equivalents registered a high of $25.3 million during FY2021, and its lowest value of $8.2 million during FY2024.
  • Moreover, its 5-year median value for Cash & Equivalents was $10.3 million (2023), whereas its average is $12.8 million.
  • In the last 5 years, Airsculpt Technologies' Cash & Equivalents surged by 14421.43% in 2021 and then tumbled by 6206.26% in 2022.
  • Over the past 5 years, Airsculpt Technologies' Cash & Equivalents (Annual) stood at $10.4 million in 2020, then surged by 144.21% to $25.3 million in 2021, then plummeted by 62.06% to $9.6 million in 2022, then grew by 6.72% to $10.3 million in 2023, then dropped by 19.75% to $8.2 million in 2024.
  • Its Cash & Equivalents stands at $8.2 million for FY2024, versus $10.3 million for FY2023 and $9.6 million for FY2022.